JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB229537

Anti-ULK1 (phospho S555) 抗体

Anti-ULK1 (phospho S555) antibody

Be the first to review this product! Submit a review

|

(7 Publications)

Rabbit Polyclonal ULK1 phospho S555 antibody. Suitable for WB and reacts with Human samples. Cited in 7 publications. Immunogen corresponding to Recombinant Fragment Protein within Human ULK1 phospho S555.

別名を表示する

KIAA0722, ULK1, Serine/threonine-protein kinase ULK1, Autophagy-related protein 1 homolog, Unc-51-like kinase 1, ATG1, hATG1

1 Images
Western blot - Anti-ULK1 (phospho S555) antibody (AB229537)
  • WB

Supplier Data

Western blot - Anti-ULK1 (phospho S555) antibody (AB229537)

7.5% SDS-PAGE gel.

All lanes:

Western blot - Anti-ULK1 (phospho S555) antibody (ab229537) at 1/1000 dilution

Lane 1:

Untreated MCF7 (human breast adenocarcinoma cell line) whole cell extract at 60 µg

Lane 2:

MCF7, treated with 100 µM CCCP for 2 hours, whole cell extract at 60 µg

Predicted band size: 112 kDa

false

Key facts

宿主種

Rabbit

クローン性

Polyclonal

アイソタイプ

IgG

キャリアフリー

No

交差種

Human

アプリケーション

WB

applications

免疫原

Recombinant Fragment Protein within Human ULK1 phospho S555. The exact immunogen used to generate this antibody is proprietary information.

O75385

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/500 - 1/3000", "WB-species-notes": "<p></p>" }, "Mouse": { "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "" }, "Rat": { "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "" } } }

出荷温度及び保存条件

製品の状態
Liquid
精製方法
Affinity purification Immunogen
バッファー組成
pH: 7 Preservative: 0.025% Proclin 300 Constituents: 78% PBS, 20% Glycerol (glycerin, glycerine), 1% BSA
出荷温度
Blue Ice
短期保存期間
1-2 weeks
短期保存温度
+4°C
長期保存温度
-20°C
分注に関する情報
Upon delivery aliquot
保管に関する情報
Avoid freeze / thaw cycle

補足情報

This supplementary information is collated from multiple sources and compiled automatically.

ULK1 also known as Unc-51-like kinase 1 is a serine/threonine-protein kinase with a molecular mass of approximately 112 kDa. ULK1 is expressed in many tissues including the brain heart and skeletal muscle and plays a significant mechanical role in initializing autophagy—a process vital for cellular recycling and homeostasis. The protein interacts with several autophagy-related proteins to facilitate its functions.
Biological function summary

This protein serves as an essential part of the ULK1 complex which includes ATG13 FIP200 and ATG101. This complex acts as an important regulator in the initiation stage of autophagy responding to cellular nutrient status and energy levels. ULK1 activity promotes the formation of the phagophore which is important for capturing and degrading cytoplasmic content.

Pathways

ULK1 plays a major role in autophagy and mTOR signaling pathways. The mTOR complex 1 (mTORC1) inhibits ULK1 activity under nutrient-rich conditions preventing unnecessary autophagy. When nutrients are scarce mTORC1 inhibition releases ULK1 enhancing autophagy initiation. ULK1 also interacts with AMPK an energy-sensing kinase adjusting cellular processes according to energy levels and promoting autophagy when necessary.

Research links ULK1 to cancer and neurodegenerative diseases. Deregulation of autophagy pathways influenced by impaired ULK1 activity associates with cancer progression and tumor growth. Cancer cells often exploit autophagy to survive in nutrient-poor environments. In neurodegenerative diseases such as Alzheimer's ULK1-mediated autophagy activity can help clear protein aggregates. Understanding ULK1 interactions with proteins like AMPK in these contexts could offer advancements in therapeutic approaches.

製品プロトコール

For this product, it's our understanding that no specific protocols are required. You can visit:

ターゲットの情報

Serine/threonine-protein kinase involved in autophagy in response to starvation (PubMed : 18936157, PubMed : 21460634, PubMed : 21795849, PubMed : 23524951, PubMed : 25040165, PubMed : 29487085, PubMed : 31123703). Acts upstream of phosphatidylinositol 3-kinase PIK3C3 to regulate the formation of autophagophores, the precursors of autophagosomes (PubMed : 18936157, PubMed : 21460634, PubMed : 21795849, PubMed : 25040165). Part of regulatory feedback loops in autophagy : acts both as a downstream effector and negative regulator of mammalian target of rapamycin complex 1 (mTORC1) via interaction with RPTOR (PubMed : 21795849). Activated via phosphorylation by AMPK and also acts as a regulator of AMPK by mediating phosphorylation of AMPK subunits PRKAA1, PRKAB2 and PRKAG1, leading to negatively regulate AMPK activity (PubMed : 21460634). May phosphorylate ATG13/KIAA0652 and RPTOR; however such data need additional evidences (PubMed : 18936157). Plays a role early in neuronal differentiation and is required for granule cell axon formation (PubMed : 11146101). Also phosphorylates SESN2 and SQSTM1 to regulate autophagy (PubMed : 25040165, PubMed : 37306101). Phosphorylates FLCN, promoting autophagy (PubMed : 25126726). Phosphorylates AMBRA1 in response to autophagy induction, releasing AMBRA1 from the cytoskeletal docking site to induce autophagosome nucleation (PubMed : 20921139). Phosphorylates ATG4B, leading to inhibit autophagy by decreasing both proteolytic activation and delipidation activities of ATG4B (PubMed : 28821708).
See full target information ULK1 phospho S555

文献 (7)

Recent publications for all applications. Explore the full list and refine your search

The Journal of physiology 601:2917-2933 PubMed37184335

2023

High-intensity interval training in the form of isometric contraction improves fatigue resistance in dystrophin-deficient muscle.

Applications

Unspecified application

Species

Unspecified reactive species

Nao Yamauchi,Katsuyuki Tamai,Iori Kimura,Azuma Naito,Nao Tokuda,Yuki Ashida,Norio Motohashi,Yoshitsugu Aoki,Takashi Yamada

Nature communications 13:1172 PubMed35246531

2022

Oxygen-sensitive methylation of ULK1 is required for hypoxia-induced autophagy.

Applications

Unspecified application

Species

Unspecified reactive species

Jingyi Li,Tao Zhang,Tao Ren,Xiaoyu Liao,Yilong Hao,Je Sun Lim,Jong-Ho Lee,Mi Li,Jichun Shao,Rui Liu

BMC cancer 21:195 PubMed33632157

2021

Blockage of AMPK-ULK1 pathway mediated autophagy promotes cell apoptosis to increase doxorubicin sensitivity in breast cancer (BC) cells: an in vitro study.

Applications

Unspecified application

Species

Unspecified reactive species

Libo Yu,Qingtao Shi,Yan Jin,Zhixin Liu,Jiaxin Li,Wenzhou Sun

Molecular medicine reports 22:1335-1341 PubMed32627001

2020

Diosmetin alleviates hypoxia‑induced myocardial apoptosis by inducing autophagy through AMPK activation.

Applications

Unspecified application

Species

Unspecified reactive species

Qijun Si,Yujie Shi,Dandan Huang,Na Zhang

Nutrients 11: PubMed31752260

2019

Exercise Mitigates the Loss of Muscle Mass by Attenuating the Activation of Autophagy during Severe Energy Deficit.

Applications

Unspecified application

Species

Unspecified reactive species

Marcos Martin-Rincon,Alberto Pérez-López,David Morales-Alamo,Ismael Perez-Suarez,Pedro de Pablos-Velasco,Mario Perez-Valera,Sergio Perez-Regalado,Miriam Martinez-Canton,Miriam Gelabert-Rebato,Julian William Juan-Habib,Hans-Christer Holmberg,Jose A L Calbet

Stem cells (Dayton, Ohio) 37:1542-1555 PubMed31574189

2019

Mitochondrial Phosphoenolpyruvate Carboxykinase Regulates Osteogenic Differentiation by Modulating AMPK/ULK1-Dependent Autophagy.

Applications

Unspecified application

Species

Unspecified reactive species

Zheng Li,Xuenan Liu,Yuan Zhu,Yangge Du,Xuejiao Liu,Longwei Lv,Xiao Zhang,Yunsong Liu,Ping Zhang,Yongsheng Zhou

Pharmacological research 148:104461 PubMed31542404

2019

Enhancement of epithelial cell autophagy induced by sinensetin alleviates epithelial barrier dysfunction in colitis.

Applications

Unspecified application

Species

Unspecified reactive species

Yong-Jian Xiong,Zhao-Bin Deng,Jia-Ni Liu,Juan-Juan Qiu,Li Guo,Pan-Pan Feng,Jing-Ru Sui,Da-Peng Chen,Hui-Shu Guo
View all publications

Abcam product promise

当社は、高品質な試薬を通じてお客様の研究を力強くサポートすることをお約束いたします。ご使用いただく各段階で、常にお客様をサポートできる体制を整えております。万が一、製品が期待通りに機能しない場合は、「Abcam Product Promise」による当社保証制度に基づき、安心してご利用いただけます。
保証に関する詳細については利用規約をご確認ください。

関連製品

Select an associated product type
Alternative Product
Primary Antibodies

AB133747

Anti-ULK1 (phospho S556) antibody [EPR6156]

primary-antibodies

ulk1-phospho-s556-antibody-epr6156-ab133747

0

(0 reviews)

Alternative Product
Primary Antibodies

AB177472

Anti-ULK1 antibody [EPR6153(2)]

primary-antibodies

ulk1-antibody-epr61532-ab177472

0

(0 reviews)

Alternative Product
Primary Antibodies

AB179458

Anti-ULK1 (phospho S467) antibody [EPR6153(2)-118]

primary-antibodies

ulk1-phospho-s467-antibody-epr61532-118-ab179458

0

(0 reviews)

Alternative Product
Primary Antibodies

AB240080

Anti-ULK1 (phospho S556) antibody [EPR6156] - BSA and Azide free

primary-antibodies

ulk1-phospho-s556-antibody-epr6156-bsa-and-azide-free-ab240080

0

(0 reviews)

Alternative Product
Primary Antibodies

AB131210

Anti-ULK1 (phospho S623) antibody [EPR6154]

primary-antibodies

ulk1-phospho-s623-antibody-epr6154-ab131210

0

(0 reviews)

Alternative Product
Primary Antibodies

AB133766

Anti-ULK1 (phospho S638) antibody [EPR6155]

primary-antibodies

ulk1-phospho-s638-antibody-epr6155-ab133766

0

(0 reviews)

Alternative Product
Primary Antibodies

AB155971

Anti-ULK1 (phospho S450) antibody [EPR6152]

primary-antibodies

ulk1-phospho-s450-antibody-epr6152-ab155971

0

(0 reviews)

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com